METHOD AND SYSTEM FOR LOCALIZATION OF AN ORAL CLEANING DEVICE

    公开(公告)号:US20200069042A1

    公开(公告)日:2020-03-05

    申请号:US16348305

    申请日:2017-11-01

    Abstract: A method (600) for estimating a location of an oral care cleaning device (10), including the steps of: (i) providing (610) an oral cleaning device comprising a sensor (28), a guidance generator (46), a feedback component (48), and a controller (30); (ii) providing (620) a guided cleaning session to the user comprising a plurality of time intervals separated by a cue to switch from a first location within the mouth to a second location; (iii) generating (630) sensor data from the sensor; (iv) estimating (640), based on the generated sensor data, the location of the oral care device during the plurality of time intervals; (v) generating (650) a model to predict the user's cleaning behavior; and (vi) determining (660) the location of the oral care device based on the estimated location of the oral care device and the model of the user's cleaning behavior.

    DIAGNOSTICS OF GINGIVITIS
    4.
    发明公开

    公开(公告)号:US20230393149A1

    公开(公告)日:2023-12-07

    申请号:US18236453

    申请日:2023-08-22

    Abstract: Disclosed is an in vitro method for assessing the presence of gingivitis in a human subject. The method is based on the insight to determine a selection of three biomarker proteins. Accordingly, in a saliva sample of the subject the concentrations are measured of the proteins Hepatocyte growth factor (HGF) and Interleukin-1β (IL-1β), and at least one of C reactive protein (CRP) and Haemoglobin. Based on the concentrations as measured, a value is determined reflecting the joint concentrations for said proteins. This value is compared with a threshold value reflecting in the same manner the joint concentrations associated with the absence of gingivitis or periodontitis. The comparison allows to assessing whether the testing value is indicative of the presence of gingivitis in said subject. Thereby, typically, a testing value reflecting a joint concentration above the joint concentration reflected by the threshold, is indicative of the presence of gingivitis.

    CLASSIFICATION OF PERIODONTITIS PATIENTS

    公开(公告)号:US20210181209A1

    公开(公告)日:2021-06-17

    申请号:US16758902

    申请日:2018-10-18

    Abstract: Disclosed is a system, a kit, a use and an in vitro method for assessing whether a human patient suffering from periodontitis has mild periodontitis or advanced periodontitis. The system and method are based on the insight to apply a clustering technique to a reference set of patient data, and then further discriminating the sets of bio markers to be applied. The clusters are determined on the basis of the biomarkers Hepatocyte Growth Factor (HGF), Matrix metalloproteinase 8 (MMP8), and Matrix metalloproteinase 9 (MMP9). The actual classification of the patient is done on the basis of the measurement of the concentrations of either of two sets of biomarkers. For one cluster these are Interleukin-1β (IL1β), Interleukin-6 (IL6), and Collagen Telopeptide. For the other cluster, these are HGF and metallopeptidase inhibitor 1 (TIMP1).

    GUM DISEASE EXAMINATION
    8.
    发明公开

    公开(公告)号:US20240355475A1

    公开(公告)日:2024-10-24

    申请号:US18684670

    申请日:2022-08-10

    CPC classification number: G16H50/20 G16H10/60 G16H50/70

    Abstract: A system for assisting a gum disease examination provides indication of an oral area to be examined during an examination of the gums of a subject under diagnosis. Historical examination data is used in respect of a set of subjects. Using this data, a first oral area to be examined is determined, and based on the historical examination data and the measurement for any previously examined oral areas during the examination, a next oral area to be examined is also determined. In this way, a sequence of oral areas to be examined is determined by the system, with the aim of making the examination as quick as possible, by obtaining a diagnosis after as few measurements as possible (when there is a positive diagnosis to be made).

    GINGIVITIS DIAGNOSTIC METHODS, USES AND KITS

    公开(公告)号:US20210164995A1

    公开(公告)日:2021-06-03

    申请号:US17046397

    申请日:2019-04-10

    Abstract: Disclosed is an in vitro method for assessing whether a human patient has gingivitis. The method is based on the insight to determine biomarker proteins. Accordingly, in a sample of saliva a patient suffering from gingivitis, the concentrations are measured of the certain protein combinations. One such combination is Alpha-1-acid glycoprotein (A1AGP) and S100 calcium-binding protein A8 (S100A8), and at least one of Hemoglobin subunit beta (Hb-beta), Keratin 4 (K-4) and Pyruvate Kinase (PK). Another combination is Alpha-1-acid glycoprotein (A1AGP), Hemoglobin subunit beta (Hb-beta) and Keratin 4 (K-4). Based on the concentrations as measured, a value is determined reflecting the joint concentrations for said proteins. This value is compared with a threshold value reflecting in the same manner the joint concentrations associated with gingivitis. The comparison allows assessing whether the testing value is indicative of the presence of gingivitis in said patient. Thereby, typically, a testing value reflecting a joint concentration below the joint concentration reflected by the threshold value is indicative for absence of gingivitis in said patient, and a testing value reflecting a joint concentration at or above the joint concentration reflected by the threshold value, is indicative for gingivitis in said patient.

    PERIODONTITIS DIAGNOSTIC METHODS, USES AND KITS

    公开(公告)号:US20210109113A1

    公开(公告)日:2021-04-15

    申请号:US17046430

    申请日:2019-04-11

    Abstract: Disclosed is an in vitro method for assessing whether a human patient has periodontitis. The method is based on the insight to determine biomarker proteins. Accordingly, in a sample of saliva a patient suffering from periodontitis, the concentrations are measured of two or more of the proteins Matrix metalloproteinase-8 (MMP-8), Matrix metalloproteinase-9 (MMP-9), Pyruvate Kinase (PK) and S100 calcium-binding protein A8 (S100A8). Based on the concentrations as measured, a value is determined reflecting the joint concentrations for said proteins. This value is compared with a threshold value reflecting in the same manner the joint concentrations associated with periodontitis. The comparison allows assessing whether the testing value is indicative of the presence of periodontitis in said patient. Thereby, typically, a testing value reflecting a joint concentration below the joint concentration reflected by the threshold value is indicative for absence of periodontitis in said patient, and a testing value reflecting a joint concentration at or above the joint concentration reflected by the threshold value, is indicative for periodontitis in said patient.

Patent Agency Ranking